BIOC - Biocept, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2019
12/30/2018
12/30/2017
12/30/2016
Total Revenue
5,529
5,529
3,250
5,069
3,223
Cost of Revenue
10,978
10,978
10,052
9,345
6,920
Gross Profit
-5,449
-5,449
-6,801
-4,276
-3,697
Operating Expenses
Research Development
4,697
4,697
4,469
3,365
2,713
Selling General and Administrative
12,911
12,911
12,989
13,534
11,615
Total Operating Expenses
17,608
17,608
17,457
16,898
14,328
Operating Income or Loss
-23,057
-23,057
-24,259
-21,175
-18,025
Interest Expense
2,081
2,081
-
-
-
Total Other Income/Expenses Net
-
-
-
51
154
Income Before Tax
-25,138
-25,138
-24,570
-21,606
-18,397
Income Tax Expense
0
0
2
8
2
Income from Continuing Operations
-25,138
-25,138
-24,572
-21,614
-18,399
Net Income
-25,138
-25,138
-24,572
-21,614
-18,399
Net Income available to common shareholders
-25,260
-25,260
-25,208
-21,614
-18,399
Basic EPS
-
-
-9.01
-23.70
-57.60
Diluted EPS
-
-
-9.01
-23.70
-57.60
Basic Average Shares
-
-
2,798
908
319
Diluted Average Shares
-
-
2,798
908
319
EBITDA
-
-23,057
-23,458
-20,599
-17,703